COVID-19 Vaccines: Of Moonshots And Managed Expectations
A Podcast On The Latest Developments
A look at the competitors and the challenges facing them and global healthcare systems. Including an interview with one of the frontrunners, China’s CanSino Biologics.
You may also be interested in...
A composite endpoint conceals Actemra’s lack of mortality benefit – while life-saving dexamethasone gets EMA endorsement.
The coronavirus pandemic hurt the German group's healthcare division but helped the contract development and manufacturing activities of Merck's life sciences business.
The world is waiting for Moderna’s COVID-19 vaccine results, but meanwhile the company is exploring new avenues to secure long-term growth